The business handles everything from everyday headache medications to cold remedies to digestive health supplements. A sale could happen for over $15 billion, insiders said. The unit had sales of $3.4 billion in 2016.
GlaxoSmithKline plc ( (GSK) - Get GlaxoSmithKline plc Sponsored ADR Report ) and Reckitt Benckiser Group Plc ( (RBGLY) ) are reportedly considering making offers to buy the unit. Pfizer had said earlier this month that it would consider selling the consumer healthcare business, but did not offer a timeline.
Pfizer is perhaps best known for making viagra. Did you know Pfizer also made these popular products?
Watch More with TheStreet:
- Jim Cramer Reveals What to Watch in Alphabet's Earnings
- Apple's Former CEO Perfectly Explains Why Tech Giant Can't be a True Innovator
- America's Love for Pumpkins by the Numbers: Video
- What You're Seeing With Cord-Cutting Is Just the Tip of the Iceberg: Akamai CEO